Stocks
Xenon Pharmaceuticals Inc.XENE
NASDAQHealthcareBiotechnology$35.53
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing novel therapies for neurological and psychiatric disorders, with a lead product candidate targeting voltage-gated sodium channels for epilepsy and pain. Its pipeline includes treatments for major depressive disorder and other central nervous system conditions, making it a closely watched name in the neurology space.
52W Range: $33.38-$72.66
Congressional Interest in Xenon Pharmaceuticals Inc. (XENE)
No congressional trades have been disclosed for Xenon Pharmaceuticals Inc. (XENE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading XENE?
No congressional trades found for this stock.